An Open Label Dose Escalation Study Of E7080

Clinical trial NCT00121719 · COMPLETED

Trial details

NCT number: NCT00121719
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor or Lymphoma

Start date: 2005-07-01
Primary completion: 2009-06-19
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.